Natascha Röhlen

8PUBLICATIONS
83CO-AUTHORS
Cancer cell biologyInnate immunityMedical infection agents (incl. prions)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 03, 2026
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.

|Feb 06, 2026
Single-cell profiling reveals diverse γδ T cell subsets in ulcerative colitis.

Lena S Mayer, Jakob Arnold, Felix Roettele

|Jan 26, 2026
Hepatocellular Carcinoma - from Immunobiology to Immunotherapy.

Charlotte Rennert, Michael Schultheiß, Robert Thimme

|Feb 24, 2025
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC.

Eva Stockinger, Hendrik Luxenburger, Dominik Bettinger

|Sep 27, 2023
Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.

Natascha Roehlen, Fabian Stoehr, Lukas Müller

|Dec 21, 2022
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity.

Natascha Roehlen, Antonio Saviano, Houssein El Saghire

Pageof 2

Frequent Collaborators

3 joint publications

Robert Thimme

3 joint publications

Maike Hofmann

2 joint publications

Markus Meyer

2 joint publications

Zeina Nehme